• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

    7/23/24 7:17:00 PM ET
    $APO
    $AVTR
    $HIBB
    $QDEL
    Investment Managers
    Finance
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $APO alert in real time by email

    NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:

    • Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD:QDEL) in the S&P MidCap 400, and QuidelOrtho will replace Hibbett Inc. (NASD:HIBB) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 26. JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions.



    • Schneider National Inc. (NYSE:SNDR) will replace U.S. Silica Holdings Inc. (NYSE:SLCA) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 31. Apollo Global Management Inc. (NYSE:APO) is acquiring U.S. Silica Holdings in a deal expected to close soon pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    July 26, 2024

    S&P MidCap 400

    Addition

    Avantor

    AVTR

    Health Care

    July 26, 2024

    S&P MidCap 400

    Deletion

    QuidelOrtho

    QDEL

    Health Care

    July 26, 2024

    S&P SmallCap 600

    Addition

    QuidelOrtho

    QDEL

    Health Care

    July 26, 2024

    S&P SmallCap 600

    Deletion

    Hibbett

    HIBB

    Consumer Discretionary

    July 31, 2024

    S&P SmallCap 600

    Addition

    Schneider National

    SNDR

    Industrials

    July 31, 2024

    S&P SmallCap 600

    Deletion

    U.S. Silica Holdings

    SLCA

    Energy

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/avantor-set-to-join-sp-midcap-400-quidelortho--schneider-national-to-join-sp-smallcap-600-302204642.html

    SOURCE S&P Dow Jones Indices

    Get the next $APO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APO
    $AVTR
    $HIBB
    $QDEL

    CompanyDatePrice TargetRatingAnalyst
    Avantor Inc.
    $AVTR
    8/1/2025Buy → Hold
    Jefferies
    Schneider National Inc.
    $SNDR
    7/1/2025$28.00Outperform
    Robert W. Baird
    Schneider National Inc.
    $SNDR
    6/2/2025$32.00Neutral → Buy
    Goldman
    QuidelOrtho Corporation
    $QDEL
    5/8/2025$44.00Hold → Buy
    Jefferies
    Avantor Inc.
    $AVTR
    4/29/2025$14.00Buy → Neutral
    Goldman
    Avantor Inc.
    $AVTR
    4/28/2025$15.50Buy → Hold
    TD Cowen
    Avantor Inc.
    $AVTR
    4/28/2025$14.00Buy → Hold
    Stifel
    Avantor Inc.
    $AVTR
    4/28/2025Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $APO
    $AVTR
    $HIBB
    $QDEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Summe Gregory L bought $375,000 worth of shares (30,000 units at $12.50) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    5/27/25 4:58:03 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Summe Gregory L bought $253,000 worth of shares (20,000 units at $12.65) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    5/22/25 5:37:34 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Summe Gregory L bought $300,000 worth of shares (25,000 units at $12.00) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    5/9/25 4:51:58 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    SEC Filings

    View All

    Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Avantor, Inc. (0001722482) (Filer)

    8/13/25 5:03:52 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Avantor Inc.

    SCHEDULE 13G/A - Avantor, Inc. (0001722482) (Subject)

    8/13/25 4:58:00 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 144 filed by Schneider National Inc.

    144 - Schneider National, Inc. (0001692063) (Subject)

    8/7/25 5:12:26 PM ET
    $SNDR
    Trucking Freight/Courier Services
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avantor downgraded by Jefferies

    Jefferies downgraded Avantor from Buy to Hold

    8/1/25 1:45:47 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Robert W. Baird resumed coverage on Schneider National with a new price target

    Robert W. Baird resumed coverage of Schneider National with a rating of Outperform and set a new price target of $28.00

    7/1/25 8:26:36 AM ET
    $SNDR
    Trucking Freight/Courier Services
    Industrials

    Schneider National upgraded by Goldman with a new price target

    Goldman upgraded Schneider National from Neutral to Buy and set a new price target of $32.00

    6/2/25 8:40:20 AM ET
    $SNDR
    Trucking Freight/Courier Services
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

    SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development. In this role, Mr. Wolff will report directly to President and Chief Executive Officer Brian Blaser, and he will lead the Company's enterprise strategy, business development, government affairs and portfolio management functions. Mr. Wolff brings over two decades of leadership experience in strategy, M&A and business development across the heal

    8/19/25 4:05:00 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    S&P Global and Maestro Partner to Offer Private Equity Firms Enhanced Visibility into Asset Level Performance

    Partnership offers streamlined value creation monitoring and reporting to support decision-making NEW YORK, Aug. 19, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) and Maestro, the leading Value Creation Management platform for private equity and a S&P Global Ventures portfolio company, have announced a strategic partnership to deliver enhanced portfolio monitoring capabilities for private equity firms and their portfolio companies. This partnership includes a native integration of the Maestro platform with S&P Global's iLEVEL portfolio monitoring system, enabling automated data entry and streamlined measurement of value creation initiatives.

    8/19/25 12:09:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Asia Pacific Petroleum Conference (APPEC) to Address Key Industry Issues Facing Global Energy Markets

    Premier energy summit set for September to focus on 'Navigating Trade, Technology and Transition" SINGAPORE, Aug. 15, 2025 /PRNewswire/ -- The 41st annual Asia Pacific Petroleum Conference (APPEC) by S&P Global – Asia's leading energy conference - will take place from September 8 to 11, 2025, at the Raffles City Convention Centre in Singapore. A cornerstone of the energy industry for the past 40 years, this premier gathering of close to 1,500 industry leaders, experts and executives across 65 countries aims to explore the evolving landscape of the oil and gas sector, discussin

    8/15/25 7:01:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APO
    $AVTR
    $HIBB
    $QDEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President, S&P Global Mobility Eager William W

    4 - S&P Global Inc. (0000064040) (Issuer)

    8/19/25 4:05:15 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    New insider Eager William W claimed ownership of 6,202 shares (SEC Form 3)

    3 - S&P Global Inc. (0000064040) (Issuer)

    8/19/25 4:00:37 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    EVP, Chief HR Officer Hankamer Brittany covered exercise/tax liability with 181 shares, decreasing direct ownership by 0.11% to 171,563 units (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    8/15/25 4:35:16 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    Leadership Updates

    Live Leadership Updates

    View All

    QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

    SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development. In this role, Mr. Wolff will report directly to President and Chief Executive Officer Brian Blaser, and he will lead the Company's enterprise strategy, business development, government affairs and portfolio management functions. Mr. Wolff brings over two decades of leadership experience in strategy, M&A and business development across the heal

    8/19/25 4:05:00 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    Kodiak Gas Services Set to Join S&P SmallCap 600

    NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Kodiak Gas Services Inc. (NYSE:KGS) will replace NV5 Global Inc. (NASD: NVEE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, August 06. Acuren Corp. (NYSE:TIC) is acquiring NV5 Global in a deal expected to be completed soon pending final conditions.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector August 06, 2025 S&P SmallCap 600 Addition Kodiak Gas Services KGS Energy August 06, 2025 S&P SmallCap 600 Deletion NV5 Global NVEE Industrials For more information about S&P Dow Jones Indices, please v

    8/1/25 5:54:00 PM ET
    $KGS
    $NVEE
    $SPGI
    Natural Gas Distribution
    Utilities
    Other Consumer Services
    Consumer Discretionary

    $APO
    $AVTR
    $HIBB
    $QDEL
    Financials

    Live finance-specific insights

    View All

    QuidelOrtho Reports Second Quarter 2025 Financial Results

    ― Labs revenue grew 4% as reported and 5% in constant currency ―― Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million annualized cost savings from initiatives announced in 2024 ― ― Company reiterates full-year 2025 financial guidance ― Second Quarter 2025 Results(all comparisons are to the prior year period) Total revenue was $614 million, as reportedNon-respiratory revenue was $567 million, a decrease of 2% both as reported and in constant currency; excluding Donor Screening, non-respiratory revenue grew 1% in constant currencyLabs revenue grew 4% as reported and 5% in constant currencyImmunohematology revenue grew 4% as reported and 3% in constant currencyRespiratory

    8/5/25 4:10:00 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Apollo Reports Second Quarter 2025 Results

    NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE:APO) (together with its consolidated subsidiaries, "Apollo") today reported results for the second quarter ended June 30, 2025. Marc Rowan, Chairman and Chief Executive Officer at Apollo said, "Our second quarter results reflect the strength of Apollo's business model and the discipline with which we operate. The power of our origination capabilities were on full display, helping to drive record quarterly organic inflows and Fee Related Earnings. In a dynamic environment, we remain focused on investing and innovating behind long-term growth themes — retirement, wealth, industrial renaissance, and the public-p

    8/5/25 6:30:00 AM ET
    $APO
    Investment Managers
    Finance

    GeoWealth Secures $38 Million in Series C Funding Led by Apollo

    GeoWealth and Apollo form strategic partnership to transform how private market funds are integrated into model portfolios for the RIA community GeoWealth, a proprietary technology and turnkey asset management platform (TAMP), today announced that it has raised a $38 million Series C funding round led by Apollo (NYSE:APO). In tandem, GeoWealth and Apollo have formed a strategic partnership to expand access to customizable public-private model portfolios for registered investment advisors (RIAs). The previously announced investment from BlackRock, J.P. Morgan Asset Management and Kayne Anderson Capital Advisors (sub-advised by Composition Capital) is included in the Series C funding tota

    8/4/25 8:00:00 AM ET
    $APO
    Investment Managers
    Finance

    $APO
    $AVTR
    $HIBB
    $QDEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    12/6/24 10:11:24 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13D/A filed by QuidelOrtho Corporation

    SC 13D/A - QuidelOrtho Corp (0001906324) (Subject)

    11/21/24 5:10:19 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    11/14/24 1:28:35 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care